Agendas of Public Meetings Held by the Committee
February 9, 2012
The Pew Charitable Trusts
901 E Street, NW
Washington, DC 20004
Welcome and Overview
Ada Sue Hinshaw, Ph.D., R.N.
Committee Chair
Presentation of the Charge from the National Vaccine Program Office
Bruce Gellin, M.D., M.P.H.
Deputy Assistant Secretary for Health
Director, National Vaccine Program Office, U.S. Department of Health and Human Services
Review of the IOM Committee to Review Adverse Effects of Vaccines
Ellen Wright Clayton, J.D., M.D.
Chair of the IOM Committee to Review Adverse Effects of Vaccines
Craig-Weaver Professor of Pediatrics, Vanderbilt University
National Vaccine Information Center Perspectives
Barbara Loe Fisher
Co-Founder and President, National Vaccine Information Center
Provider Perspectives
Gary Freed, M.D., M.P.H.
Professor, Department of Health Management and Policy, University of Michigan School of Public Health
Director, Division of General Pediatrics
The Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery
The Use of Clinical Trials for Childhood Vaccines
Susan Ellenberg, Ph.D.
Professor of Biostatistics and Associate Dean for Clinical Research
Perelman School of Medicine at the University of Pennsylvania
Ethical Issues in Clinical Trials
Robert (Skip) Nelson, M.D., Ph.D.
Senior Pediatric Ethicist/Lead Medical Officer, Food and Drug Administration
National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC)
Melinda Wharton, M.D., M.P.H.
Deputy Director, NCIRD, CDC
Captain, U.S. Public Health Service
Immunization Safety Office (ISO), CDC
Frank DeStefano, M.D., M.P.H.
Director, ISO, CDC
Data and Approaches in National and International Immunization Studies
Saad Omer, Ph.D., M.P.H., M.B.B.S.
Assistant Professor, Hubert Department of Global Health Epidemiology, Emory University Rollins School of Public Health
Assistant Professor, Emory Vaccine Center
Immune Profiling Research
Chuck Hackett, Ph.D.
Deputy Director, Division of Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases
OPEN SESSION—Opportunity for Attendee Comments
Adjourn
March 8, 2012
Talaris Conference Center
4000 NE 41st Street
Seattle, WA 98105
Welcome and Overview
Ada Sue Hinshaw, Ph.D., R.N.
Committee Chair
Welcome from Washington State Department of Health
Mary Selecky
Secretary of Health, Washington State Department of Health
Maxine Hayes, M.D., M.P.H.
State Health Officer, Washington State Department of Health
Washington State’s Immunization Programs
Janna Bardi, M.P.H.
Office Director, Immunization and Child Profile Office
Washington State Department of Health
Findings on Alternative Immunization Schedule Practices
Douglas Opel, M.D., M.P.H.
Assistant Professor of Pediatrics, Adjunct Assistant Professor of Bioethics and Humanities
University of Washington
Treuman Katz Center for Pediatric Bioethics
Seattle Children’s Research Institute
Assessing the Safety of Vaccines at the FDA: Pre- and Postlicensure Evaluations
Marion F. Gruber, Ph.D. (by phone)
Acting Director, Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Office of Medical Products and Tobacco
Food and Drug Administration
Karen Farizo, M.D. (by phone)
Acting Associate Director for Medical Policy and Safety
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Office of Medical Products and Tobacco
Food and Drug Administration
Issues Leading to Vaccine Hesitancy
Douglas Opel, M.D., M.P.H.
Assistant Professor of Pediatrics, Adjunct Assistant Professor of Bioethics and Humanities
University of Washington
Treuman Katz Center for Pediatric Bioethics
Seattle Children’s Research Institute
Process for Immunization Schedule Recommendations
Edgar Marcuse, M.D., M.P.H.
Professor of Pediatrics, Adjunct Professor of Epidemiology, University of Washington
Associate Medical Director, Quality Improvement, Seattle Children’s Hospital
Decision Making at Advisory Committee on Immunization Practices in Response to Unanticipated Adverse Event Detection
Jeffrey Duchin, M.D.
Chief, Communicable Disease Epidemiology and Immunization Section
Public Health
Seattle and King County, Washington
Provider Self-Efficacy and Tools to Improve Immunization Rates
David Grossman, M.D., M.P.H.
Medical Director, Preventive Care
Group Health Cooperative
Group Health Research Institute and the Vaccine Safety Datalink
Michael L. Jackson, Ph.D., M.P.H.
Assistant Scientific Investigator
Group Health Research Institute
OPEN SESSION—Opportunity for Attendee Comments
Adjourn
May 29, 2012
The Pew Charitable Trusts
901 E Street, NW
Washington, DC 20004
Welcome and Overview
Ada Sue Hinshaw, Ph.D., R.N.
Committee Chair
U.S. Childhood Immunization Schedule Decisions
Margaret B. Rennels, M.D.
Professor of Pediatrics, University of Maryland School of Medicine (retired)
Independent Consultant
Question and Answer
Vaccine Policy and Safety Surveillance in the United Kingdom
Elizabeth Miller (by phone)
Head, Immunization Division
Communicable Disease Surveillance Centre
Health Protection Agency, Colindale, United Kingdom
Question and Answer
Vaccine Decisions: Policy Making and Priority Setting in Canada
Charlotte Moore Hepburn, M.D., F.R.C.P.C., F.A.A.P.
Lead, Child Health Policy Initiative
Assistant Professor, University of Toronto School of Medicine
Staff Paediatrician, Division of Paediatric Medicine, The Hospital for Sick Children
Question and Answer
Advisory Committee on Immunization Practices Decision Making
Melinda Wharton, M.D., M.P.H.
Deputy Director, National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Captain, U.S. Public Health Service
Question and Answer
Alternative Immunization Schedules: A Feasibility Study for Evaluating Vaccine Safety and the Risk of Pertussis
Jason Glanz, Ph.D.
Epidemiologist, Institute for Health Research
Kaiser Permanente Colorado
Question and Answer
Study Designs for the Safety Evaluation of Different Childhood Immunization Schedules
Martin Kulldorff, Ph.D.
Professor, Biostatistician, Department of Population Medicine Harvard
Medical School and Harvard Pilgrim Health Care Institute
Question and Answer
Commentary on Commissioned Paper and Other Committee Considerations
Michael A. Stoto, Ph.D.
Professor of Health Systems Administration and Population Health
Georgetown University School of Nursing and Health Studies
Question and Answer
OPEN SESSION—Opportunity for Attendee Comments
Adjourn